Apollo Hospitals gains after Q3 PAT jumps 35% YoY to Rs 502 cr; board declares Rs 10 interim dividend

Apollo Hospitals gains after Q3 PAT jumps 35% YoY to Rs 502 cr; board declares Rs 10 interim dividend


Profit before tax (PBT) increased 27.19% YoY to Rs 682 crore in the quarter ended 31 December 2025.

EBITDA grew by 26.64% to Rs 965 crore in Q3 FY26, up from Rs 762 crore in Q3 FY25. This includes Apollo 24/7 costs of Rs 124 crore during the quarter (including Rs 38 crore in non-cash ESOP charges), compared to Rs 141 crore in Q3 FY25.

On a segmental front, revenue from Healthcare Services rose 14% YoY to Rs 3,183 crore. Revenue from Apollo Health and Lifestyle (AHLL) stood at Rs 467 crore, up 20% YoY, while revenue from Apollo HealthCo reached Rs 2,827 crore, also up 20% YoY.

 

As on 31 December 2025, Apollo Hospitals had 8,072 operating beds across the network (excluding AHLL & managed beds). The overall occupancy for hospitals was at 67% in Q3FY26 vs 68% in the same period in the previous year.

Dr. Prathap C Reddy, Chairman, Apollo Hospitals Enterprise Ltd. said, Q3FY26 reflects the fundamental strength and clinical depth of Apollos integrated care model. Across our network, teams are consistently delivering strong outcomes through disciplined execution in patient safety, quality, and experience. This quarter, sustained investments in advanced clinical capability translated into meaningful progress across key specialties from Apollo OMR completing 150 robotic joint replacement surgeries in its first 150 days, to the expansion of our stroke care network in Chennai with nine advanced stroke labs, strengthening rapidaccess care and outcomes.

We further reinforced our differentiated leadership in neurosciences with the launch of a dedicated Centre of Excellence for Parkinsons disease and Deep Brain Stimulation care in Chennai, strengthened comprehensive oncology care through the Save My Stomach early detection programme at Apollo Cancer Centres, and expanded high-acuity capability with a dedicated heart and lung transplant unit in Karnataka. In parallel, partnerships such as the MoU with Coal India reflect Apollos vision to expand access to standardized, high-quality healthcare by building integrated preventive and tertiary care pathways for large workforce populations.

Apollos transplant programme reflects the depth, scale, and discipline of our clinical systems. As one of the worlds busiest solid organ transplant programmes, our teams now perform an average of five solid organ transplants each day. Cumulatively, we have completed more than 21,000 kidney transplants and over 5,000 liver transplantsbecoming the first hospital group in India and the region to reach this landmarkalong with 159 heart transplants and 232 lung transplants. These outcomes are the result of standardized clinical pathways, multidisciplinary expertise, and a sustained commitment to patient safety, ethics, and long-term outcomes.

The Union Budget provides an important tailwind to Indias aspiration to become a global destination for healthcare. The proposal to support states in establishing five regional medical hubs through public private partnership is a strategic step toward building a high-quality, well-coordinated Medical Value Travel ecosystem. At Apollo, we view Medical Value Travel as a long-term national mission that reflects Indias depth of clinical expertise, outcomes excellence, and cost advantage. We will continue to work closely with policymakers and state partners to strengthen international patient pathways, expand high-acuity capacity, and ensure seamless coordination across pre-travel evaluation, clinical care, and post-discharge followup.

The board has declared an interim dividend of Rs 10 per share for the financial year 2026. The record date for the same has been fixed as February 16 and it will be paid on or before February 27.

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nations first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country. Apollo Hospitals has emerged as Asias foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics and several Retail Health models.

Powered by Capital Market – Live News



Source link

Apollo Hospitals gains after Q3 PAT jumps 35% YoY to Rs 502 cr; board declares Rs 10 interim dividend

Indo SMC secures an order of Rs 40.77 cr


Indo SMC has received intimation of receipt of purchase order worth Rs. 40.77 crore from M/s. Shree Balaji Com LLP for supply of HT Air Insulated Bus Duct for 650 AM under Ground System.

HT Air Insulated Bus Ducts rated for 650A in underground systems are specialized electrical power distribution components used for high-tension (HT) power transmission. They provide efficient, reliable alternatives to cables in demanding environments.

Powered by Capital Market – Live News

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Feb 11 2026 | 9:32 AM IST



Source link

Apollo Hospitals gains after Q3 PAT jumps 35% YoY to Rs 502 cr; board declares Rs 10 interim dividend

GHV Infra Projects bags Rs 135-cr civil works order


GHV Infra Projects has secured a work order worth around Rs 135 crore from MHK Buildcon LLP for the construction of a water storage pond and other associated/miscellaneous civil works in Haryana.

The project is to be executed within a period of 22 months. The order has been awarded by a domestic entity and involves civil construction works. The company said that neither the promoter nor the promoter group has any interest in the awarding entity, and the contract does not fall under related-party transactions.

GHV Infra Projects is in the business of infrastructure and construction.

The companys standalone net profit surged 3,907.1% to Rs 11.22 crore on a 17,401.9% soar in revenue from operations to Rs 183.77 crore in Q2 FY26 over Q2 FY25.

 

Shares of GHV Infra Projects rose 5% to close at Rs 249.90 on the BSE.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Feb 11 2026 | 8:04 AM IST



Source link

Stock Market LIVE: GIFT Nifty hints at positive start amid mixed cues; Asian markets extend gains

Stock Market LIVE: GIFT Nifty hints at positive start amid mixed cues; Asian markets extend gains


Stock Market LIVE Updates, Wednesday, February 11, 2026: Indian equity benchmark indices, Sensex and Nifty, are likely to witness a positive opening on Wednesday amid mixed global cues. 

 

Around 6:50 AM, the GIFT Nifty was trading at 26,050.5 levels, up by 89 points or 0.34 per cent.  
As a part of the MSCI’s February 2026 index review, Aditya Birla Capital and L&T Finance have been added to the MSCI Global Standard Index. IRCTC is the only Indian stock that has been excluded from the index. AU Small Finance Bank will see a weight increase in the index due to a float adjustment. Following the rejig, India’s weight in the MSCI Standard Index remains unchanged at 14.1 per cent. The number of Indian companies in the index will increase to 165 from 164. 

 


Asian markets opened higher, continuing their rally despite AI concerns and lacklustre economic data weighing on Wall Street sentiment. Last checked, Japan’s Nikkei 225 index was up 2.28 per cent, Australia’s S&P/AXS 200 rose 1.21 per cent, while South Korea’s KOSPI rose 0.04 per cent. 

 


In the US markets, the S&P 500 and Nasdaq ended lower on Tuesday, while the Dow Jones Industrial Average edged up to its third straight record close as investors digested weak retail sales data and awaited a key labour market report. The US retail sales report for December showed consumer spending was unchanged, falling short of economists’ expectations for a 0.4% monthly increase, according to a Dow Jones survey. The S&P 500 index fell 0.33 per cent, the Nasdaq Composite was down 0.59 per cent, while the Dow Jones Industrial Average rose 0.10 per cent. 


Q3 results today


Mahindra & Mahindra, Divi’s Labs, Ashok Leyland, Max Financial Services, Patanjali Foods, SJVN, AstraZeneca Pharma, Kirloskar Oil Engines, TBO Tek, Bayer CropScience, Amara Raja Energy, Avanti Feeds, IRCON, ConCord Biotech, Jupiter Wagons, Black Box, Procter & Gamble Health, Mrs Bectors Food, Garware Technical Fibres, Fiem Industries, Surya Roshni, Technocraft Industries India, among others will announce their quarterly earnings today.


IPO Corner

In the mainboard segment, IPOs of Fractal Analytics and Aye Finance will enter their last day of public subscription. In the SME space, Grover Jewells and Brandman Retail will make their debut on the NSE SME platform. The basis of allotment for Biopol Chemicals and PAN HR Solutions will be finalised today. 



Source link

'Surprised by market reaction to Kevin Warsh's nomination to the US Fed'

'Surprised by market reaction to Kevin Warsh's nomination to the US Fed'



Kevin Warsh’s nomination as the next Fed chair surprised the markets, especially precious metals segment. US-based Aditya Bhave, senior US economist at BofA Global Research, tells Puneet Wadhwa in an email interview that with the US midterm elections in November, they expect trade policy to pivot to a more supportive stance for growth. The recent announcement of the India-US trade deal, he said, has reduced uncertainty around India’s growth outlook. Edited excerpts:

 


What’s your view on India?

 


Our India strategists believe that the Indian markets (Nifty Index) are already trading in the upper band of long-term valuations and thus valuation expansion/re-rating led upside is likely limited.  They believe returns from here on out would mirror earnings growth, which could accelerate to 14 per cent in FY27 from the mid-single digit earnings growth Nifty witnessed in FY25 & FY26. They, therefore, see 13 per cent upside for Nifty by the year-end (Dec’26).

 
 


How do you see the economic growth in India play out over the next 12 months?

 


India weathered significant external headwinds last year. Our India economists recently upgraded their forecasts on the back of improvement in the data flow. They now look for 6.8 per cent GDP growth in FY27. They see private consumption growing consistently above 7 per cent through the next 12 months, though investment spending is likely to moderate. 

 

The recent announcement of the India-US trade deal has reduced uncertainty around India’s growth outlook. Our India team doesn’t see further cuts by the Reserve Bank of India (RBI) in the next 12 months, unless there is some weakness in growth following the change in the GDP series. They see this as a low-probability outcome. 

 


How do you think the US economy will shape up in 2026 in the backdrop of a challenging geopolitical situation?

 


We are bullish on the US economy. We are forecasting 2.8 per cent GDP (gross domestic product) growth in 2026. Our optimism is driven by five factors. First, the OBBBA (One Big Beautiful Bill Act), which was passed last summer, should add 0.3-0.4pp to GDP growth this year via consumer and capex stimulus. Second, the 75 basis points (bp) of Fed cuts late last year should work their way through the economy in coming months.

 


Third, with the midterm elections in November, we expect trade policy to pivot to a more supportive stance for growth. Fourth, AI-related investment should continue to grow at a solid pace this year. Last, the government shutdown late last year will mechanically boost 2026 GDP growth.

 


Do you see actions of the US Federal Reserve (US Fed) being driven more by political compulsions rather than economic concerns?

 


Kevin Warsh, who has been nominated to be the Chair of the Federal Reserve, has called for significant rate cuts. His premise is partly that AI-related productivity growth will be disinflationary. However, if GDP growth is robust in the first half of the year – as we expect – it might be difficult for him to convince the rest of the Federal Open Market Committee (FOMC) that cuts are needed to support the economy. Especially if there is no progress on inflation, which has been stuck above the Fed’s target for nearly five years.

 


Did the global financial markets, especially the precious metals, over-reacted to the Fed chair nominee?

 


We were surprised by the market reaction to Kevin Warsh’s nomination. His recent comments on Fed policy rates have been dovish. Although he has retained a hawkish stance on the Fed’s balance sheet, it will be very challenging to shrink the $6.6 trillion balance sheet absent significant banking deregulation. Even then, the scope for reduction is only modest.

 


We would not expect Warsh to be hawkish in practice on either policy rates or the balance sheet. It’s possible that the market response to his nomination was more due to pricing out of outcomes under other nominees, who had taken a far more dovish stance than Warsh on balance-sheet policy.

 


What are the key risks to the US economy over the next few months?

 


The proximate downside risk to the US economy is that the labor market, which has been soft for a few quarters, deteriorates significantly further. If the unemployment rate rises to 5 per cent or more, spending could collapse under the weight of labor income losses. Markets over-reacted to the drop in the unemployment rate to 4.4 per cent in December. It had been rising for a few consecutive months before that, and we see about a one-in-four chance that it will start increasing steadily again.

 

Another risk is that AI investment could slow if power supply turns out to be a major bottleneck. If an AI investment slowdown (or any other factor) causes a big sell-off in tech stocks, which will probably also have knock-on effects for consumption, given that higher-income spending appears to be partly driven by equity wealth effects. Any shock to the US economy would have substantial knock-on effects on the rest of the world. That said, the dollar will most likely remain the world’s reserve currency. This reduces the urgency for fiscal tightening by generating additional demand for US Treasury securities. 

 


What’s the road ahead for US bond yields and 10-year GSec in India?

 


Our rates strategists expect US 10-year yields to remain range-bound, ending the year at 4.25 per cent. We see upside risks if the strong growth that we are forecasting causes a pickup in inflation, or the Fed cuts rates too aggressively. 

 


It’s a similar story in India: our economists think yields will remain in the 6.65-6.75 per cent range, because positioning is light. Stepping back, deficit concerns are coming to the fore across developed markets, not just in Japan. As a result, in the last several months there has been broad debasement of fiat currencies in favor of commodities, particularly gold.



Source link

Apollo Hospitals gains after Q3 PAT jumps 35% YoY to Rs 502 cr; board declares Rs 10 interim dividend

Bharat Heavy Electricals secures work order of Rs 2,800 cr


Bharat Heavy Electricals (BHEL) has received a Letter of Acceptance from Bharat Coal Gasification and Chemicals (BCGCL), a joint venture company of BHEL and Coal India (CIL). The contract is for Design, Engineering, Supply of equipment, Civil works, Erection, Commissioning and O&M
Services for Syngas Purification Plant (LSTK 2 Package) of BCGCL’s Coal to 2000 TPD Ammonium Nitrate Project at Lakhanpur, Jharsuguda
District, Odisha, India. The contract is valued at approximately Rs 2,800 crore.

Powered by Capital Market – Live News

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Feb 10 2026 | 9:31 PM IST



Source link

YouTube
Instagram
WhatsApp